PP
NVO

Pingora Partners’s Novo Nordisk NVO Stock Holding History

Pingora Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
2,200
+400
+22% +$17.2K 0.06% 101
2026
Q1 		$66.2K Buy
1,800
+1,360
+309% +$64.4K 0.04% 117
2025
Q4 		$22.4K Buy
440
+200
+83% +$10.2K 0.01% 161
2025
Q3 		$13.3K Hold
240
– – 0.01% 175
2025
Q2 		$16.6K Hold
240
– – 0.01% 167
2025
Q1 		$16.7K Buy
240
+50
+26% +$4.13K 0.01% 168
2024
Q4 		$16.3K Hold
190
– – 0.01% 182
2024
Q3 		$22.6K Hold
190
– – 0.02% 170
2024
Q2 		$27.1K Hold
190
– – 0.02% 165
2024
Q1 		$24.4K Buy
+190
New +$22.6K 0.02% 180

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Pingora Partners's NVO Position: Q2 2026 in Review

Pingora Partners increased its Novo Nordisk (NVO) stake by 22% in Q2 2026, buying an estimated $17.2K and bringing the position to 2,200 shares worth $105K. The position accounts for 0.06% of the portfolio, ranked #101.

Pingora Partners first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Pingora Partners held 2,200 shares of Novo Nordisk worth $105K as of Q2 2026.
  • Pingora Partners bought 400 Novo Nordisk shares in Q2 2026, an estimated $17.2K.
  • Novo Nordisk made up 0.06% of Pingora Partners's portfolio in Q2 2026, its #101 holding.
  • Pingora Partners first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.